Clinical Trial Update: Efficacy and Tolerability of Antistax® in Male and Female Patients Suffering From Chronic Venous Insufficiency [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and tolerability of Antistax for chronic venous insufficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Insufficiency

Drugs mentioned

• Antistax (red vine leaf extract)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Venous Insufficiency | Phase 3 | Status: COMPLETED